Showing results (3051-3060 of 3,897) with videos related to
Sort By:
Pageof 390
Disease Markers|July 21, 2022
GRAMD1A Is a Biomarker of Kidney Renal Clear Cell Carcinoma and Is Associated with Immune Infiltration in the Tumour MicroenvironmentYifu Liu, Shengqiang Fu, Zhicheng Zhang, et al.Disease Markers|July 21, 2022
miR-26a-5p Suppresses Wnt/β-Catenin Signaling Pathway by Inhibiting DNMT3A-Mediated SFRP1 Methylation and Inhibits Cancer Stem Cell-Like Properties of NSCLCJie Yu, Zhe Ge, Shunqiong Chen, et al.Disease Markers|July 21, 2022
Circulating miRNAs as Epigenetic Mediators of Periodontitis and Preeclampsia AssociationWangmeng Zhang, Qishan Wu, Juan Su, et al.Disease Markers|July 25, 2022
Inhibitory Effect of miR-339-5p on Glioma through PTP4A1/HMGB1 PathwayBuyi Zheng, Shouyi Wang, Huanan Shen, et al.Disease Markers|July 25, 2022
Characteristics of HBV Novel Serum Markers across Distinct Phases in Treatment-Naïve Chronic HBV-Infected PatientsHao Liao, Le Li, Wei V Zheng, et al.Disease Markers|July 18, 2022
Human Umbilical Cord Mesenchymal Stem Cell-Derived Extracellular Vesicles Carrying MicroRNA-29a Improves Ovarian Function of Mice with Primary Ovarian Insufficiency by Targeting HMG-Box Transcription Factor/Wnt/β-Catenin SignalingTian Gao, Yi Cao, Min Hu, et al.Disease Markers|July 18, 2022
A Predictive Model Based on Pyroptosis-Related Gene Features Can Effectively Predict Clear Cell Renal Cell Carcinoma Prognosis and May Be an Underlying Target for ImmunotherapyYufu Wang, Jinhui Liu, Lishuo Zhang, et al.Disease Markers|July 18, 2022
GLTP Is a Potential Prognostic Biomarker and Correlates with Immunotherapy Efficacy in Cervical CancerYan-Long Shi, Ming-Bo Liu, Hong-Ting Wu, et al.Disease Markers|July 29, 2022
LINC01419 Promotes the Proliferation of Hepatoma Cells by Recruiting XRCC5 and Regulating Its Phosphorylation to Repair DNA DamagePan Liu, Xu Zhang, Qiang Fu, et al.Disease Markers|July 29, 2022
Effect of Vitamin D Combined with Recombinant Human Growth Hormone in Children with Growth Hormone DeficiencyPingping Wang, Xuefeng Jin, Yan Zhang, et al.Pageof 390